Viviana Navas, MD(@md_viviana) 's Twitter Profileg
Viviana Navas, MD

@md_viviana

The Letica Family Endowed Chair. Section head, Heart Failure I Program Director, Cardiology Fellowship. NCH Healthcare @NCH_Heart. Animal lover 🇨🇴

ID:1046123084598693888

calendar_today29-09-2018 19:42:34

495 Tweets

2,2K Followers

1,6K Following

Follow People
Nikhil Narang, MD(@Nikhil15) 's Twitter Profile Photo

Another breakthrough in the field of TTR Amyloid care, onus still on cardiology community as a whole to identify cases earlier as benefit of stabilizers attenuated in pts with NYHA III and above sx Sunil Pauwaa MD Gregory Macaluso

account_circle
Nikhil Narang, MD(@Nikhil15) 's Twitter Profile Photo

In this JACC Journals August issue, baseline frailty was reversed in ~ 50% of pts undergoing percutaneous mitral valve repair w/ severe primary/secondary MR

📎 jacc.org/doi/10.1016/j.…

In this @JACCJournals #JACCHF August issue, baseline frailty was reversed in ~ 50% of pts undergoing percutaneous mitral valve repair w/ severe primary/secondary MR 📎 jacc.org/doi/10.1016/j.…
account_circle
Viviana Navas, MD(@md_viviana) 's Twitter Profile Photo

Q: Should Beta-Bloquers be used in Heart Failure if the EF is not reduced???
A: In this large cohort of pts with HF and EF of >40% BB use was associated with higher risk of hospitalization as EF increased
Further randomized studies are needed. jacc.org/doi/10.1016/j.…

Q: Should Beta-Bloquers be used in Heart Failure if the EF is not reduced??? A: In this large cohort of pts with HF and EF of >40% BB use was associated with higher risk of hospitalization as EF increased Further randomized studies are needed. jacc.org/doi/10.1016/j.…
account_circle
David R. Axline, MD, FACC(@PU84) 's Twitter Profile Photo

ASSOCIATION BETWEEN RIGHT VENTRICULAR TO PULMONARY CIRCULATION UNCOUPLING AND RENAL BLOOD FLOW IN HEART FAILURE - ScienceDirect ⁦Roberto J. Cubeddu, MD⁩ ⁦Viviana Navas, MD⁩ The right heart continues to impress sciencedirect.com/science/articl…

account_circle
David R. Axline, MD, FACC(@PU84) 's Twitter Profile Photo

Role of aldosterone in the mid‐ and long‐term left ventricular remodelling after acute myocardial infarction: the REMI study - Monzo - European Journal of Heart Failure - Wiley Online Library Viviana Navas, MD⁩ ⁦ onlinelibrary.wiley.com/doi/abs/10.100…

account_circle
David R. Axline, MD, FACC(@PU84) 's Twitter Profile Photo

Variation in Hemodynamic Assessment and Interpretation: A Call to Standardize the Right Heart Catheterization - ScienceDirect ⁦Ricardo Martinez-Ruiz⁩ ⁦Gaston A. Cudemus, MD⁩ ⁦Roberto J. Cubeddu, MD⁩ ⁦Viviana Navas, MD⁩ The Professor must opine! sciencedirect.com/science/articl…

account_circle
David R. Axline, MD, FACC(@PU84) 's Twitter Profile Photo

Pulmonary artery pulsatility index in patients with tricuspid valve regurgitation: a simple non-invasive tool for risk stratification | European Heart Journal - Cardiovascular Imaging | ⁦Roberto J. Cubeddu, MD⁩ ⁦⁦Viviana Navas, MD⁩ ⁦ academic.oup.com/ehjcimaging/ad…

account_circle
Brett Sperry, MD(@BrettSperryMD) 's Twitter Profile Photo

Big day for patients with ATTR amyloidosis, as the topline results of ATTRIBUTE-CM are positive!

Acoramidis showed significant benefit for the hierarchical composite of all-cause mortality, CV hospitalization, NTproBNP, and 6MW distance.

investor.bridgebio.com/news-releases/…

Big day for patients with ATTR amyloidosis, as the topline results of ATTRIBUTE-CM are positive! Acoramidis showed significant benefit for the hierarchical composite of all-cause mortality, CV hospitalization, NTproBNP, and 6MW distance. investor.bridgebio.com/news-releases/…
account_circle
David R. Axline, MD, FACC(@PU84) 's Twitter Profile Photo

Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure | Circulation: Cardiovascular Imaging ⁦Roberto J. Cubeddu, MD⁩ ⁦Viviana Navas, MD⁩ ahajournals.org/doi/abs/10.116…

account_circle
Adrian da Silva(@adrianjdasilva) 's Twitter Profile Photo

New in JACC HF:

Cardiac Myosin Inhibitors in Obstructive HCM: practical considerations, challenges, and opportunities across clinical phenotypes JACC Journals

New in JACC HF: Cardiac Myosin Inhibitors in Obstructive HCM: practical considerations, challenges, and opportunities across clinical phenotypes @JACCJournals #HCM #HF #MyosinInhibitor
account_circle
Jacob Abraham, MD(@Abraham_Jacob) 's Twitter Profile Photo

A must-read for clinicians who treat HF🫀shock, emphasizing best practices:

🔑Early identification (often subtle in SCAI B)
🔑Hemodynamic profiling of shock with PAC
🔑 Hemodynamically-targeted therapy
🔑 Decongestion
🔑 Early MCS
🔗 bit.ly/3py8V1y

A must-read for clinicians who treat HF🫀shock, emphasizing best practices: 🔑Early identification (often subtle in SCAI B) 🔑Hemodynamic profiling of shock with PAC 🔑 Hemodynamically-targeted therapy 🔑 Decongestion 🔑 Early MCS 🔗 bit.ly/3py8V1y
account_circle
Jenny Thibodeau, MD, MSCS(@JTThibs) 's Twitter Profile Photo

Is it CardioMEMS' time to shine? In JACC Journals , Akshay Desai shows that pts w HF & prior hospitalization for HF or ⬆️ NPs had improved outcomes with hemodynamic-guided therapy. Does this finding change your practice?
👀 jacc.org/doi/10.1016/j.…

Is it CardioMEMS' time to shine? In @JACCJournals #JACCHF, @akshaydesaimd shows that pts w HF & prior hospitalization for HF or ⬆️ NPs had improved outcomes with hemodynamic-guided therapy. Does this finding change your practice? 👀 jacc.org/doi/10.1016/j.…
account_circle